$58 Profit
NKTXLong Stock
KL1688

(biotech- Phase I data for blood cancer treatment) opening drive.

00

DatePrice
Entry4/25/202214.4195
Exit4/25/202215.00
  • Total Views18
  • Position Size100
  • Percentage4.03%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
Join now or log in to leave a comment